enGene Holdings Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Ronald H. W. Cooper, with a market cap of $565.7M. As of Q3 2025, 80% of shares are held by 39 institutional investors, with FCPM III SERVICES B.V. as the largest holder at 18.82%.
Overview of institutional ownership in ENGN as of Q3 2025 with a market cap of $349.6M
Based on market cap of $349.6M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in ENGN as of Q3 2025
| Institution | Position Value |
|---|---|
FCPM III SERVICES B.V. Real Assets | $65.8M 13.15% of portfolio |
VR Adviser, LLC Venture Capital | $34.5M 1.94% of portfolio |
K Kynam Capital Management, LP Hedge Fund•Long/Short | $34.1M 2.54% of portfolio |
B Blue Owl Capital Holdings LP Institution | $22.4M 7.02% of portfolio |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | $15.9M 1.24% of portfolio |
B BRAIDWELL LP Hedge Fund•Multi-Strategy | $15.5M 0.63% of portfolio |
Deep Track Capital, LP Hedge Fund•Long/Short | $15.3M 0.43% of portfolio |
PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | $14.3M 0.41% of portfolio |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | $8.3M 0.02% of portfolio |
Frazier Life Sciences Management, L.P. Venture Capital | $7.9M 0.24% of portfolio |
Institutional buying and selling activity for ENGN in Q3 2025
| Institution | Net Bought |
|---|---|
B BRAIDWELL LP Hedge Fund•Multi-Strategy | +$15.5M +2.3M shares |
PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | +$14.3M +2.1M shares |
Frazier Life Sciences Management, L.P. Venture Capital | +$7.9M +1.2M shares |
MPM Oncology Impact Management LP Institution | +$3.6M +530.3K shares |
MORGAN STANLEY RIA/Wealth | +$563.6K +82.5K shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | +$241.3K +35.3K shares |
WELLS FARGO & COMPANY/MN Institution | +$100.5K +14.7K shares |
Hudson Bay Capital Management LP Hedge Fund•Multi-Strategy | +$75.6K +11.1K shares |
PFS Partners, LLC RIA/Wealth | +$61.5K +9.0K shares |
RAYMOND JAMES FINANCIAL INC RIA/Wealth | +$54.2K +7.9K shares |
| Institution | Net Sold |
|---|---|
Deep Track Capital, LP Hedge Fund•Long/Short | −$15.8M −2.3M shares |
BANK OF AMERICA CORP /DE/ Institution | −$9.3M −1.4M shares |
GOLDMAN SACHS GROUP INC Institution | −$5.1M −751.5K shares |
B Blue Owl Capital Holdings LP Institution | −$3.1M −450.0K shares |
ORBIMED ADVISORS LLC Hedge Fund•Sector | −$2.5M −678.0K shares |
Schonfeld Strategic Advisors LLC Hedge Fund•Multi-Strategy | −$1.0M −149.5K shares |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | −$101.1K −27.8K shares |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | −$41.5K −11.4K shares |
SUNRISE PARTNERS LIMITED PARTNERSHIP /CT Hedge Fund•Multi-Strategy | −$37.6K −10.3K shares |
TORONTO DOMINION BANK Institution | −$31.0K −4.5K shares |
Institutions that initiated new positions or completely exited ENGN in Q3 2025
| Institution | Position Value |
|---|---|
B BRAIDWELL LP Hedge Fund•Multi-Strategy | $15.5M 2.3M shares |
Frazier Life Sciences Management, L.P. Venture Capital | $7.9M 1.2M shares |
MPM Oncology Impact Management LP Institution | $3.6M 530.3K shares |
Hudson Bay Capital Management LP Hedge Fund•Multi-Strategy | $75.6K 11.1K shares |
PFS Partners, LLC RIA/Wealth | $61.5K 9.0K shares |
| Institution | Previous Position |
|---|---|
ORBIMED ADVISORS LLC Hedge Fund•Sector | $2.5M 678.0K shares |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | $101.1K 27.8K shares |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | $41.5K 11.4K shares |
SUNRISE PARTNERS LIMITED PARTNERSHIP /CT Hedge Fund•Multi-Strategy | $37.6K 10.3K shares |
WOLVERINE ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | $23.2K 6.4K shares |
NBC SECURITIES, INC. RIA/Wealth | $1.0K 380.0 shares |
Institutions with the largest Call and Put options positions in ENGN as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with ENGN as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
FCPM III SERVICES B.V. Real Assets | 13.15% $65.8M |
B Blue Owl Capital Holdings LP Institution | 7.02% $22.4M |
K Kynam Capital Management, LP Hedge Fund•Long/Short | 2.54% $34.1M |
VR Adviser, LLC Venture Capital | 1.94% $34.5M |
Omega Fund Management Inc. Venture Capital | 1.62% $3.6M |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | 1.24% $15.9M |
S SPHERA FUNDS MANAGEMENT LTD. Institution | 0.83% $3.4M |
SR ONE CAPITAL MANAGEMENT, LP Venture Capital | 0.74% $5.1M |
B BRAIDWELL LP Hedge Fund•Multi-Strategy | 0.63% $15.5M |
MPM Oncology Impact Management LP Institution | 0.59% $3.6M |
Discover hedge funds investing in ENGN

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Medical - Diagnostics & Research Healthcare | $259.5M | 7.38% | |
Biotechnology Healthcare | $249.1M | 7.08% | |
Biotechnology Healthcare | $236.3M | 6.72% |
We use cookies for analytics. See our Privacy and Cookie Policy.